Neutrophil-to-Lymphocyte Ratio and Covid-19.
作者信息
Bedel Cihan, Korkut Mustafa
机构信息
Department of Emergency Medicine Health Science University Antalya Training And Research Hospital Antalya, Turkey.
出版信息
Shock. 2021 Nov 1;56(5):874. doi: 10.1097/SHK.0000000000001712.
Abstract
摘要
相似文献
1
Neutrophil-to-Lymphocyte Ratio and Covid-19.中性粒细胞与淋巴细胞比值和新冠肺炎
Shock. 2021 Nov 1;56(5):874. doi: 10.1097/SHK.0000000000001712.
2
Lymphocyte and neutrophil count combined with intestinal bacteria abundance predict the severity of COVID-19.淋巴细胞和中性粒细胞计数与肠道细菌丰度联合预测 COVID-19 的严重程度。
Microbiol Spectr. 2024 Jan 11;12(1):e0302723. doi: 10.1128/spectrum.03027-23. Epub 2023 Dec 13.
3
Comment on ''Can the neutrophil/lymphocyte ratio (NLR) have a role in the diagnosis of coronavirus 2019 disease (COVID-19)?''.关于“中性粒细胞/淋巴细胞比值（NLR）在2019冠状病毒病（COVID-19）诊断中能否发挥作用？”的评论
Rev Assoc Med Bras (1992). 2021 Jul 9;67Suppl 1(Suppl 1):168-169. doi: 10.1590/1806-9282.67.Suppl1.20200812. eCollection 2021.
4
The Association of Age, Sex, and RT-PCR Results with the Lymphocyte and Neutrophil Counts in SARS-CoV-2 Infection: A Cross-sectional Analysis of 1450 Iranian Patients with COVID-19.年龄、性别和 RT-PCR 结果与 SARS-CoV-2 感染中的淋巴细胞和中性粒细胞计数的关系：对 1450 例伊朗 COVID-19 患者的横断面分析。
Iran J Allergy Asthma Immunol. 2021 Apr 17;20(2):129-139.
5
[Comment on article: "Neutrophil-to-lymphocyte ratio as a serum biomarker associated with community acquired pneumonia"].[对文章《中性粒细胞与淋巴细胞比值作为社区获得性肺炎相关血清生物标志物》的评论]
Rev Med Inst Mex Seguro Soc. 2021 Aug 13;59(3):181.
6
Neutrophil-to-lymphocyte ratio is independently associated with COVID-19 severity: An updated meta-analysis based on adjusted effect estimates.中性粒细胞与淋巴细胞比值与新冠病毒疾病严重程度独立相关：基于调整后效应估计值的最新荟萃分析
Int J Lab Hematol. 2021 Oct;43(5):e254-e260. doi: 10.1111/ijlh.13475. Epub 2021 Jan 27.
7
Are neutrophil-to-lymphocyte ratios and large unstained cells different in hospitalized COVID-19 PCR-positive patients with and without diabetes mellitus?患有和未患有糖尿病的COVID-19 PCR检测呈阳性的住院患者的中性粒细胞与淋巴细胞比率及大未染色细胞是否存在差异？
Eur Rev Med Pharmacol Sci. 2022 Aug;26(16):5963-5970. doi: 10.26355/eurrev_202208_29537.
8
Prognostic Role of Neutrophil to Lymphocyte Ratio in COVID-19 Patients: Still Valid in Patients That Had Started Therapy?中性粒细胞与淋巴细胞比值对 COVID-19 患者预后的预测价值：在已经开始治疗的患者中仍然有效吗？
Front Public Health. 2021 Jun 15;9:664108. doi: 10.3389/fpubh.2021.664108. eCollection 2021.
9
Neutrophil-to-Lymphocyte ratio as a potential biomarker for disease severity in COVID-19 patients.中性粒细胞与淋巴细胞比值可作为 COVID-19 患者疾病严重程度的潜在生物标志物。
J Glob Antimicrob Resist. 2020 Sep;22:862-863. doi: 10.1016/j.jgar.2020.07.029. Epub 2020 Aug 15.
10
Leukocyte differential and reactive lymphocyte counts from Sysmex XN analyzer in the evaluation of SARS-CoV-2 infection.XN 分析仪检测白细胞分类和反应性淋巴细胞计数在评估 SARS-CoV-2 感染中的应用。
Scand J Clin Lab Invest. 2021 Sep;81(5):394-400. doi: 10.1080/00365513.2021.1929445. Epub 2021 Jun 9.
引用本文的文献
1
Predicting survival in patients with SARS-CoV-2 based on cytokines and soluble immune checkpoint regulators.基于细胞因子和可溶性免疫检查点调节因子预测新型冠状病毒2型患者的生存率
Front Cell Infect Microbiol. 2024 Nov 25;14:1397297. doi: 10.3389/fcimb.2024.1397297. eCollection 2024.
2
A Risk Model for 28-Day in-Hospital Mortality in 173 COVID-19 Patients Admission to ICU: A Retrospective Study.173例入住重症监护病房的COVID-19患者28天院内死亡率的风险模型：一项回顾性研究
Infect Drug Resist. 2024 Mar 23;17:1171-1184. doi: 10.2147/IDR.S447326. eCollection 2024.
3
Correlation of serum interleukin-6 levels and neutrophil-lymphocyte ratio in the severity of COVID-19.血清白细胞介素-6 水平与中性粒细胞-淋巴细胞比值与 COVID-19 严重程度的相关性。
F1000Res. 2023 Sep 22;12:1189. doi: 10.12688/f1000research.132157.1. eCollection 2023.
4
Increased Pro Th1 And Th17 Transcriptional Activity In Patients With Severe COVID-19.重症 COVID-19 患者 Th1 和 Th17 转录活性增加。
Int J Med Sci. 2023 Feb 21;20(4):530-541. doi: 10.7150/ijms.80498. eCollection 2023.
5
Development and Validation of a Predictive Nomogram with Age and Laboratory Findings for Severe COVID-19 in Hunan Province, China.基于年龄和实验室检查结果的湖南省重症新型冠状病毒肺炎预测列线图的开发与验证
Ther Clin Risk Manag. 2022 May 17;18:579-591. doi: 10.2147/TCRM.S361936. eCollection 2022.
6
Immunopathogenesis of patients with COVID-19: from the perspective of immune system 'evolution' and 'revolution'.COVID-19 患者的免疫发病机制：从免疫系统“进化”和“革命”的角度来看。
Expert Rev Mol Med. 2022 Apr 12;24:e19. doi: 10.1017/erm.2022.12.
Zotero 插件